Skip to main navigation Skip to search Skip to main content

Challenges to Diabetes Care Innovation. The Case of a Major Public Institution in Mexico

  • Miguel Ángel González Block
  • , Sandra Patricia Díaz Portillo
  • , Hortensia Reyes Morales
  • , Joel Rodriguez-Saldana
  • , Emilio Gutiérrez Calderón
  • , Carlos Chivardi
  • , Lucero Cahuana-Hurtado
  • , José Moreno
  • , Emily Vargas Riaño
  • , Nelly Salgado
  • , Blanca Estela Pelcastre-Villafuerte
  • Universidad Anáhuac. Huixquilucan
  • Evisys Consulting
  • National Institute of Public Health
  • Multidisciplinary Diabetes Centre
  • UNAM

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

The Mexican Institute of Social Security (IMSS) is strengthening diabetes care through piloting the Chronic Disease Preventive Model (CDPM) that includes intensive diabetes education, interdisciplinary care teams, and intensification of insulin therapy and of HbA1c monitoring. To address CDPM implementation challenges, we analyzed care bottlenecks and facilitators and barriers in the internal and external institutional contexts. The CDPM planning process is facilitated by clinical protocols, role redefinition, and an incremental approach to implementation. However, the overly large size of IMSS together with its verticality, excessive bureaucratic control, and limitation of autonomy at the primary care level restrain staff motivation, coordination, and the alignment of interests along the innovation value chain. CDPM implementation faces weak support by governance at the highest levels within IMSS while patients expect IMSS to be a provider of medications rather than to be a partner in the provision of comprehensive care. For CDPM to be fully implemented, IMSS would have to increase by 16.2% the total number of family physicians while increasing by more than 1000% the number of professionals in clinical psychology and nutrition. CDPM would require a 335% increase in diabetes care spending, mostly for increased insulin treatment and human resources. Spending for diabetes would have to increase from the current 14.3% of total health spending to 20.6%. Spending on diabetes-related complications, however, would decrease. Reforms should be developed with universities, professional associations, and the IMSS workers’ trade union as well as with the pharmaceutical industry to ensure breakthroughs in new professional and technical profiles and less costly pharmaceuticals. Reforms should be supported on digital innovation to reduce treatment costs while improving adherence, quality of care, monitoring, and evaluation. Reforms should include a national diabetes care policy to empower persons living with diabetes.

Original languageEnglish
Title of host publicationThe Diabetes Textbook
Subtitle of host publicationClinical Principles, Patient Management and Public Health Issues, Second Edition
PublisherSpringer International Publishing
Pages421-433
Number of pages13
ISBN (Electronic)9783031255199
ISBN (Print)9783031255182
DOIs
StatePublished - 1 Jan 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 1 - No Poverty
    SDG 1 No Poverty
  2. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  3. SDG 9 - Industry, Innovation, and Infrastructure
    SDG 9 Industry, Innovation, and Infrastructure

Keywords

  • Diabetes care innovation challenges
  • Mexico

Fingerprint

Dive into the research topics of 'Challenges to Diabetes Care Innovation. The Case of a Major Public Institution in Mexico'. Together they form a unique fingerprint.

Cite this